skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission

Authors:
 [1];  [2];  [3];  [3];  [2];  [4];  [5]
  1. UCIBIO@REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia (FFUP), Universidade do Porto, R. Jorge Viterbo Ferreira 228 4050-313 Porto Portugal, CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra-PRD Portugal
  2. Serviço de Dermatologia, Centro Hospitalar e Universitário de Coimbra, Universidade de Coimbra, Coimbra Portugal
  3. CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra-PRD Portugal
  4. Centro de Investigação em Ciências da Saúde (CICS), Universidade da Beira Interior, Covilhã Portugal
  5. UCIBIO@REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia (FFUP), Universidade do Porto, R. Jorge Viterbo Ferreira 228 4050-313 Porto Portugal
Publication Date:
Sponsoring Org.:
USDOE Office of Nuclear Energy (NE), Fuel Cycle Technologies (NE-5)
OSTI Identifier:
1400924
Grant/Contract Number:  
OBS/58600/2004
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
British Journal of Dermatology
Additional Journal Information:
Journal Name: British Journal of Dermatology Journal Volume: 174 Journal Issue: 2; Journal ID: ISSN 0007-0963
Publisher:
Wiley-Blackwell
Country of Publication:
United Kingdom
Language:
English

Citation Formats

Coimbra, S., Oliveira, H., Neuparth, M. J., Proença, J. B., Figueiredo, A., Rocha-Pereira, P., and Santos-Silva, A. Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission. United Kingdom: N. p., 2015. Web. doi:10.1111/bjd.14013.
Coimbra, S., Oliveira, H., Neuparth, M. J., Proença, J. B., Figueiredo, A., Rocha-Pereira, P., & Santos-Silva, A. Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission. United Kingdom. doi:10.1111/bjd.14013.
Coimbra, S., Oliveira, H., Neuparth, M. J., Proença, J. B., Figueiredo, A., Rocha-Pereira, P., and Santos-Silva, A. Wed . "Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission". United Kingdom. doi:10.1111/bjd.14013.
@article{osti_1400924,
title = {Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission},
author = {Coimbra, S. and Oliveira, H. and Neuparth, M. J. and Proença, J. B. and Figueiredo, A. and Rocha-Pereira, P. and Santos-Silva, A.},
abstractNote = {},
doi = {10.1111/bjd.14013},
journal = {British Journal of Dermatology},
number = 2,
volume = 174,
place = {United Kingdom},
year = {2015},
month = {11}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
DOI: 10.1111/bjd.14013

Citation Metrics:
Cited by: 3 works
Citation information provided by
Web of Science

Save / Share: